DK8892D0 - Humant proteingen - Google Patents

Humant proteingen

Info

Publication number
DK8892D0
DK8892D0 DK9288A DK8892A DK8892D0 DK 8892 D0 DK8892 D0 DK 8892D0 DK 9288 A DK9288 A DK 9288A DK 8892 A DK8892 A DK 8892A DK 8892 D0 DK8892 D0 DK 8892D0
Authority
DK
Denmark
Prior art keywords
mammal
human
expression system
dna sequence
casein
Prior art date
Application number
DK9288A
Other languages
Danish (da)
English (en)
Inventor
Lennart Hansson
Mats Stroemqvist
Sven Bergstroem
Olle Hernell
Jan Toernell
Original Assignee
Symbicom Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbicom Ab filed Critical Symbicom Ab
Priority to DK9288A priority Critical patent/DK8892D0/da
Publication of DK8892D0 publication Critical patent/DK8892D0/da
Priority to US08/256,799 priority patent/US6222094B1/en
Priority to AT93902110T priority patent/ATE229071T1/de
Priority to DK93902110T priority patent/DK0625197T3/da
Priority to AU33464/93A priority patent/AU3346493A/en
Priority to EP93902110A priority patent/EP0625197B1/fr
Priority to ES93902110T priority patent/ES2188592T3/es
Priority to JP51286793A priority patent/JP3467272B2/ja
Priority to DE69332537T priority patent/DE69332537T2/de
Priority to PT93902110T priority patent/PT625197E/pt
Priority to CA002128110A priority patent/CA2128110A1/fr
Priority to PCT/DK1993/000024 priority patent/WO1993015196A1/fr
Priority to US08/462,437 priority patent/US6232094B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/101—Bovine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK9288A 1992-01-23 1992-01-23 Humant proteingen DK8892D0 (da)

Priority Applications (13)

Application Number Priority Date Filing Date Title
DK9288A DK8892D0 (da) 1992-01-23 1992-01-23 Humant proteingen
PCT/DK1993/000024 WO1993015196A1 (fr) 1992-01-23 1993-01-25 And codant la kappa-caseine, procede permettant d'obtenir cette proteine et son utilisation
AU33464/93A AU3346493A (en) 1992-01-23 1993-01-25 DNA encoding kappa-casein, process for obtaining the protein and use thereof
AT93902110T ATE229071T1 (de) 1992-01-23 1993-01-25 Für kappa-casein kodierende dna, verfahren zur gewinnung des proteins und seine verwendung
DK93902110T DK0625197T3 (da) 1992-01-23 1993-01-25 DNA, der koder for k-kasein, fremgangsmåde til opnåelse af proteinet og anvendelse af dette
US08/256,799 US6222094B1 (en) 1992-01-23 1993-01-25 Transgenic non-human mammal expressing the DNA sequence encoding kappa casein mammary gland and milk
EP93902110A EP0625197B1 (fr) 1992-01-23 1993-01-25 And codant la kappa-caseine, procede permettant d'obtenir cette proteine et son utilisation
ES93902110T ES2188592T3 (es) 1992-01-23 1993-01-25 Adn que codifica para la kappa-caseina, proceso para la obtencion de la proteina y uso de la misma.
JP51286793A JP3467272B2 (ja) 1992-01-23 1993-01-25 κ−カゼインをコードするＤＮＡ，そのタンパク質を得る方法および用途
DE69332537T DE69332537T2 (de) 1992-01-23 1993-01-25 Für kappa-casein kodierende dna, verfahren zur gewinnung des proteins und seine verwendung
PT93902110T PT625197E (pt) 1992-01-23 1993-01-25 Adn que codifica a k-cseina, processo para a obtencao da proteina e sua utilizacao
CA002128110A CA2128110A1 (fr) 1992-01-23 1993-01-25 Adn codant pour la kappa-caseine, methode de production de la proteine et utilisation
US08/462,437 US6232094B1 (en) 1992-01-23 1995-06-05 DNA encoding human κ casein and process for obtaining the protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK9288A DK8892D0 (da) 1992-01-23 1992-01-23 Humant proteingen

Publications (1)

Publication Number Publication Date
DK8892D0 true DK8892D0 (da) 1992-01-23

Family

ID=8089602

Family Applications (2)

Application Number Title Priority Date Filing Date
DK9288A DK8892D0 (da) 1992-01-23 1992-01-23 Humant proteingen
DK93902110T DK0625197T3 (da) 1992-01-23 1993-01-25 DNA, der koder for k-kasein, fremgangsmåde til opnåelse af proteinet og anvendelse af dette

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK93902110T DK0625197T3 (da) 1992-01-23 1993-01-25 DNA, der koder for k-kasein, fremgangsmåde til opnåelse af proteinet og anvendelse af dette

Country Status (11)

Country Link
US (2) US6222094B1 (fr)
EP (1) EP0625197B1 (fr)
JP (1) JP3467272B2 (fr)
AT (1) ATE229071T1 (fr)
AU (1) AU3346493A (fr)
CA (1) CA2128110A1 (fr)
DE (1) DE69332537T2 (fr)
DK (2) DK8892D0 (fr)
ES (1) ES2188592T3 (fr)
PT (1) PT625197E (fr)
WO (1) WO1993015196A1 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633076A (en) * 1989-12-01 1997-05-27 Pharming Bv Method of producing a transgenic bovine or transgenic bovine embryo
AU4537393A (en) * 1992-06-15 1994-01-04 Gene Pharming Europe Bv Production of recombinant polypeptides by bovine species and transgenic methods
US6204431B1 (en) 1994-03-09 2001-03-20 Abbott Laboratories Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk
US5750176A (en) * 1994-03-09 1998-05-12 Abbott Laboratories Transgenic non-human mammal milk comprising 2'-fucosyl-lactose
NZ279676A (en) * 1994-03-09 1998-04-27 Abbott Lab Humanized milk produced by non-human transgenic mammal transformed with a heterologous gene coding for human enzyme producing human oligosaccharides and glycoconjugates
EP0750671A1 (fr) * 1994-03-09 1997-01-02 Abbott Laboratories Animaux transgeniques produisant des oligosaccharides et des glycoconjugues
US5712250A (en) * 1994-09-16 1998-01-27 Abbott Laboratories Product for inhibition of human rotavirus infection
JPH10505828A (ja) * 1994-09-16 1998-06-09 アボツト・ラボラトリーズ ヒトロタウイルス感染の阻害
US5576300A (en) * 1994-09-16 1996-11-19 Abbott Laboratories Method for inhibition of human rotavirus infection
US6455280B1 (en) 1998-12-22 2002-09-24 Genset S.A. Methods and compositions for inhibiting neoplastic cell growth
US6514825B1 (en) * 2000-06-28 2003-02-04 Conexant Systems, Inc. Technique for reducing 1/f noise in MOSFETs
CN102180944A (zh) 2001-10-10 2011-09-14 诺和诺德公司 肽的重构和糖缀合
AU2004236174B2 (en) 2001-10-10 2011-06-02 Novo Nordisk A/S Glycopegylation methods and proteins/peptides produced by the methods
ZA200700168B (en) 2001-10-10 2010-02-24 Novo Nordisk As Remodeling and glycoconjugation of peptides
CA2487322C (fr) * 2002-05-24 2013-07-16 A2 Corporation Limited Methode de genotypage d'animaux
US7011949B2 (en) * 2002-09-30 2006-03-14 Agilent Technologies, Inc. Methods and compositions for producing labeled probe nucleic acids for use in array based comparative genomic hybridization applications
US7982008B2 (en) 2002-11-27 2011-07-19 David Bar-Or Treatment of diseases and conditions mediated by increased phosphorylation
WO2005081904A2 (fr) 2004-02-20 2005-09-09 The Burnham Institute Glucose antimicrobien et procedes de fabrication
US7968762B2 (en) * 2004-07-13 2011-06-28 Van Andel Research Institute Immune-compromised transgenic mice expressing human hepatocyte growth factor (hHGF)
AU2006217901B2 (en) * 2005-02-24 2011-09-29 Dsm Ip Assets B.V. Blood pressure lowering peptides from glycomacropeptide
BRPI0616323A2 (pt) * 2005-09-20 2011-06-14 Prolacta Bioscience Inc mÉtodo para determinar se um fluido mamÁrio doado foi obtido a partir de um indivÍduo especÍfico
WO2010119088A2 (fr) * 2009-04-15 2010-10-21 Bodo Melnik Lait et produits lactés modifiés pour présenter un indice insulinémique réduit et/ou une activité mitogène réduite
WO2013058825A1 (fr) * 2011-04-07 2013-04-25 Cornell University Monomères silyles aptes à former un multimère dans une solution aqueuse et leurs procédés d'utilisation
US9812699B2 (en) 2011-10-05 2017-11-07 Oned Material Llc Silicon nanostructure active materials for lithium ion batteries and processes, compositions, components and devices related thereto
EA023387B1 (ru) * 2012-10-08 2016-05-31 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pFK3, ОБЕСПЕЧИВАЮЩАЯ СИНТЕЗ РЕКОМБИНАНТНОГО ПЕПТИДА RL3, ЯВЛЯЮЩЕГОСЯ АНАЛОГОМ ФРАГМЕНТА КАППА-КАЗЕИНА ЧЕЛОВЕКА, РЕКОМБИНАНТНЫЙ ШТАММ БАКТЕРИЙ ESCHERICHIA COLI XL1-Blue/pFK3 И РЕКОМБИНАНТНЫЙ ПЕПТИД RL3 - АНАЛОГ ФРАГМЕНТА КАППА-КАЗЕИНА ЧЕЛОВЕКА, ОБЛАДАЮЩИЙ АПОПТОТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К РАКОВЫМ КЛЕТКАМ
EA023475B1 (ru) * 2012-10-08 2016-06-30 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pFK4, ОБЕСПЕЧИВАЮЩАЯ СИНТЕЗ РЕКОМБИНАНТНОГО ПЕПТИДА RL4, ЯВЛЯЮЩЕГОСЯ АНАЛОГОМ ФРАГМЕНТА КАППА-КАЗЕИНА ЧЕЛОВЕКА, РЕКОМБИНАНТНЫЙ ШТАММ БАКТЕРИЙ ESCHERICHIA COLI XL1-BLUE/pFK4 И РЕКОМБИНАНТНЫЙ ПЕПТИД RL4 - АНАЛОГ ФРАГМЕНТА КАППА-КАЗЕИНА ЧЕЛОВЕКА, ОБЛАДАЮЩИЙ АПОПТОТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К РАКОВЫМ КЛЕТКАМ
EP3977862A1 (fr) 2014-08-21 2022-04-06 Perfect Day, Inc. Compositions comprenant une caséine et procédés de production de celles-ci
CA3034678A1 (fr) 2016-08-25 2018-03-01 Perfect Day, Inc. Produits alimentaires comprenant des proteines laitieres et des proteines d'origine non animale, et leurs procedes de production
CN114206126A (zh) * 2019-05-02 2022-03-18 新培养公司 奶酪和酸奶样组合物以及相关方法
EP3970501A1 (fr) 2020-09-18 2022-03-23 Baio Procédé de production de substituts de fromage
US20230337692A1 (en) 2020-09-18 2023-10-26 Standing Ovation Method for producing cheese substitutes
WO2022072718A1 (fr) 2020-09-30 2022-04-07 Nobell Foods, Inc. Protéines de lait recombinantes et compositions les comprenant
US10947552B1 (en) 2020-09-30 2021-03-16 Alpine Roads, Inc. Recombinant fusion proteins for producing milk proteins in plants
US10894812B1 (en) 2020-09-30 2021-01-19 Alpine Roads, Inc. Recombinant milk proteins
US11771105B2 (en) 2021-08-17 2023-10-03 New Culture Inc. Dairy-like compositions and related methods
WO2023197003A2 (fr) * 2022-04-08 2023-10-12 Mozza Foods, Inc. Fabrication de fromage avec des protéines de soja
EP4328240A1 (fr) * 2022-08-25 2024-02-28 Real Deal Milk S.L. Production de proteines recombinees
WO2024102436A1 (fr) * 2022-11-10 2024-05-16 The Johns Hopkins University Système de modulation de signalisation de récepteur de tyrosine kinase et ses méthodes d'utilisation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0081570A4 (fr) 1981-06-12 1985-09-02 Univ Ohio Transformation genetique de zygotes.
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
JPS61158793A (ja) * 1984-11-14 1986-07-18 Takeda Chem Ind Ltd ヒト・リゾチ−ムの合成遺伝子
DE122007000007I2 (de) * 1986-04-09 2010-12-30 Genzyme Corp Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
EP0561140B1 (fr) 1986-05-20 2002-01-30 The General Hospital Corporation Méthodes d'étude pharmacocinétique de l'expression de l'insuline à l'aide de mammifère transgénique non-humaine
GB8615942D0 (en) 1986-06-30 1986-08-06 Animal & Food Research Council Peptide production
WO1988001648A1 (fr) 1986-08-28 1988-03-10 Immunex Corporation Expression de proteines heterologues par des mammiferes transgeniques en lactation
EP0832981A1 (fr) * 1987-02-17 1998-04-01 Pharming B.V. Séquences d'ADN pour diriger des protéines vers les glandes mammaires, afin d'être secrétées efficacement
US4873316A (en) 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
US6020015A (en) * 1988-09-22 2000-02-01 Gaull; Gerald E. Infant formula compositions and nutrition containing genetically engineered human milk proteins
CA2065866A1 (fr) 1989-09-11 1991-03-12 Vermuri B. Reddy Production d'une hormone de croissance dans le lait d'un animal transgenique
EP0502976B1 (fr) 1989-12-01 1996-07-03 Pharming B.V. Production de polypeptides recombines par des especes bovines et procedes transgeniques
US5795611A (en) 1989-12-20 1998-08-18 Slattery; Charles W. Human infant formulas containing recombinant human alpha-lactalbumin and beta-casein
US5391497A (en) 1992-10-13 1995-02-21 University Of Colorado Foundation, Inc. Human k-casein

Also Published As

Publication number Publication date
DK0625197T3 (da) 2003-03-24
ES2188592T3 (es) 2003-07-01
PT625197E (pt) 2003-04-30
EP0625197A1 (fr) 1994-11-23
ATE229071T1 (de) 2002-12-15
DE69332537T2 (de) 2003-09-04
US6222094B1 (en) 2001-04-24
WO1993015196A1 (fr) 1993-08-05
JP3467272B2 (ja) 2003-11-17
DE69332537D1 (de) 2003-01-16
JPH07503136A (ja) 1995-04-06
EP0625197B1 (fr) 2002-12-04
AU3346493A (en) 1993-09-01
CA2128110A1 (fr) 1993-08-05
US6232094B1 (en) 2001-05-15

Similar Documents

Publication Publication Date Title
DK8892D0 (da) Humant proteingen
US5959171A (en) Method for the production of biologically active polypeptides in a mammal's
DE69534907D1 (de) Transgene schweine, die den menschlichen blutgerinnungsfaktor viii exprimieren
EP0264166B1 (fr) Animaux transformés génétiquement sécrétant une protéine désirée dans le lait
US5750172A (en) Transgenic non human mammal milk
US5895833A (en) Production of human recombinant collagen in the milk of transgenic animals
Meade et al. Bovine alphas1-casein gene sequences direct high level expression of active human urokinase in mouse milk
DE69027683D1 (de) Herstellung rekombinanter polypeptide durch rinder und transgene methoden
DE69133372D1 (de) Transgenes, nicht-menschliches säugetier das die amyloidbildende pathologie der alzheimerschen krankheit zeigt
US20020129387A1 (en) Expression of proteins in milk
Ebert et al. Transgenic farm animals: progress report
WOODROOFE et al. Long-term consequences of interleukin-6 overexpression in transgenic mice
US6727405B1 (en) Transgenic animals secreting desired proteins into milk
Westphal Transgenic mammals and biotechnology
Wilmut et al. Production of pharmaceutical proteins in milk
US20030005468A1 (en) Methods and vectors for improving nucleic acid expression
BG94777A (bg) Метод за произвеждане на нечовешки трансгенетични животни чрез въвеждане на екзогенна днк в соматични и зародишни клетки на животните
Rottmann et al. Liposome‐mediated gene transfer via sperm cells. High transfer efficiency and persistence of transgenes by use of liposomes and sperm cells and a murine amplification element
KR950704477A (ko) 형질 전환된 내피 세포(transformed endothelial cells)
CN101855352A (zh) 乳腺特异性人促红细胞生成素表达载体、转基因动物和利用其产生人促红细胞生成素的方法
Castro et al. Transgenic rabbits for the production of biologically-active recombinant proteins in the milk
Stinnakre et al. Quantitative collection of milk and active recombinant proteins from the mammary glands of transgenic mice
Berg Human recombinant collagen in the milk of transgenic animals
Whitelaw et al. Animal bioreactors.
KR960031600A (ko) 인체 락토페린의 생산 방법

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment